Javascript is disabled

Javascript seems to be disabled. This will break some core site features. Please enable javascript or revisit this site from another device.

Accepted abstracts for NECTM10

Below you will find all the accepted abstracts for the conference. These will all presented either as oral presentations during one of our five Free Communications Sessions or as posters. Where no link is provided, the author has not given permission for the abstract to be published.

Poster presentations

Divided into abstract categories, in the order they are presented at the conference.

1. Pre-Travel Risk Assessment & Management

1.1 Assessment Architect: How to Profile Traveler Risk and Ensure Adherence in 180 Seconds
Maureen MacConnell

1.2 Common exposure, rare disease: How clinicians communicate rabies risk and support vaccination decisions for travellers
Sarah McGuinness

1.3 Vaccine literacy among Italian travelers: A web-based survey using a brief assessment tool
Sara Ciampini

1.4 Chikungunya risk in travelers returning to France, 2025.
Eric Plennevaux

1.5 Clinical Incident Calls to the NaTHNaC Advice Line, 2019-2025: Trends, Patterns, and Implications for Practice
Catherine Wolfe

1.6 Risk perception as key factor in seeking pre-travel advice for European destinations: an interview study among Dutch travellers
Iris Scholte

1.7 Preventing Female Genital Multilation (FGM) in traveling girls
Claire van Nispen tot Pannerden and Priscilla dos Santos

1.8 Pre-travel health service in Finland
Terhi Heinasmaki

1.9 Travel Medicine in Reverse: A mixed methods approach
Marabelle Nana Essandoh

2. Malaria

2.1 A Rare Hypersensitivity Reaction to Quinine, a Long-Standing Antimalarial Agent: A Case of Probable DRESS
Rachel Sheppard

2.2 Plasma microRNA and Lipid Profile Dynamics in Patients with Malaria: A Prospective Multicenter Study
Marta González

2.3 From Boarding Gate to Malaria Diagnosis: A Prospective App-Based Cohort Study of Incidence and Prevention Dynamics
Sami Alcedo

2.4 Subclinical malaria among pregnant migrants from Sub Saharan Africa living in Sweden: A prospective screening study
Katja Wyss

2.5 Identifying malaria prevention information needs: insights from UK national advice line enquiries, 2019-2025
Catherine Wolfe

2.6 A review of 15 years of cryptic malaria in the United Kingdom
Parisha Katwa

3. Arboviral Diseases and Other Vector-Borne Infections

3.1 Four-year antibody persistence after a single-dose live-attenuated chikungunya virus vaccine (VLA1553, IXCHIQ®) in adults aged 18 years and above
Natascha Sattler

3.2 Fatal Dengue in Travellers from Non-Endemic Countries: A Targeted Review of Reported Deaths (1995–2025)
Robert Steffen

3.3 Dengue, chikungunya and Zika in travellers: a single-centre cross-sectional study
Milan Trojanek

3.4 10-Year Analysis of Vector-borne Travel-Related Infectious Diseases in Singapore (2015 – 2024)
Cherie See

3.5 Fatal human West Nile Virus infections in Europe (2020-2025): a systematic review
Patricia Schlagenhauf

3.6 From Paraguay to Cuba: outbreak-driven imported chikungunya and its implications in the Vaccine Era
Fernando de la Calle-Prieto

3.7 Lassa Fever Beyond Borders: Implications for Travel Medicine from Nigeria – A Narrative Review
Babalola Ibisola

3.8 What do travellers know about arboviral infections? Insights from a survey of NHS travel clinic attendees
Oliver Koch

4. Vaccines

4.1 Immunogenicity and Safety of a Single Booster Dose of Purified Vero Rabies Vaccine-Serum Free (PVRV-NG2) Following 2- and 3-Dose Pre-exposure Prophylaxis in Adults: Results from a Phase III Study
Catherine Huoi

4.2 Benefit risk assessment for a next generation Purified Vero Rabies Vaccine-Serum Free (PVRV-NG2) in pre- and post- exposure prophylaxis
Catherine Huoi

4.3 Shifting Confidence and Knowledge in Dengue Vaccination within the UK: Two Years On
Dipti Patel

4.4 Heterogeneity in Rabies Pre-Exposure Prophylaxis Recommendations Across European Continent: A Comprehensive Analysis
Christèle Augard

4.5 Post-marketing tolerance data for the first chikungunya vaccine over 12 months in vaccinated French populations.
Eric Plennevaux

4.6 Assessing Dengue Vaccinee Characteristics and Adverse Effect Profiles – A Single-Centre Prospective Cohort Study.
Lotte Van Den Heuvel

4.7 Disease transmission and mass gatherings: a case study on meningococcal infection during Hajj & Umrah
Laurent Coudeville

4.8 Implementation and Adherence to National Indications for Dengue Vaccination in Italian Travel Medicine Clinics: A Survey-Based Assessment
Francesco Marchiori

4.9 Long-Term Safety and Cell-Mediated Immunity Before and After Booster of Tetravalent Dengue Vaccine TAK-003 in Healthy Adults in Dengue Nonendemic United States
Sanjay Patel

4.10 Timely Vaccination in MS Patients: Collaboration Between Neurologists, MS Nurses, and Public Health Services (GGD)
Priscilla dos Santos-Moreno Cardoso

5. Food- and Waterborne Diseases

5.1 Reducing Standby Antibiotics for Traveller’s Diarrhoea in NHS Lothian Travel Clinics
Oliver Koch

5.2 Evaluation of the Biosynex AMPLIQUICK™ Fecal Parasitology assays in a Belgian travel clinic
Jasmine Coppens

5.3 Leptospirosis Acquired by Travel-Related Recreational Freshwater Exposure: A Systematic Review
Gregory D. Hawley

5.4 Treatment Outcomes and Refractory Disease in Giardiasis: A two-center study of commonly used antimicrobials in Finland, 2007–2020
Jukka-Pekka Pietilä

5.5 Imported giardiasis and metronidazole treatment failure in returning travellers, Prague, 2016–2025
Vyacheslav Grebenyuk

6. Special Risk Traveller Groups

6.1 A trip to Singapore, an opportunity to vaccinate a transplate patient
Francesco Marchiori

7. Innovation & Digital Health in Travel Medicine

7.1 Use of Acetazolamide for the Prevention of High-Altitude Illness: A Mixed Methods Social Media Sentiment Analysis
Cillian McGarry

7.2 Digitalisation of the International Certificate of Vaccination or Prophylaxis (ICVP)
Remko Schats

7.3 What Next: Predicting Symptom Occurrence in Travellers Using the ITIT App
Nadja Hedrich

7.4 Travellers to Africa: an Analysis of ITIT Illness and Geolocation Data
Nadja Hedrich

7.5 Mobile applications in travel medicine: a systematic review of information quality and surveillance performance
Tri Puji Astuti

8. Surveillance, Outbreaks & Epidemiologic Trends

8.1 Recent Yellow Fever epidemics in Africa and South America
Yael Thollot

8.2 Epidemiology of imported dengue cases in England, Wales and Northern Ireland: a ten-year review
Iman Mohamed

9. Injuries, Trauma, Safety & Security in Travel)